Merck to showcase 100+ oncology studies at 2026 ASCO meeting
Highlighting KEYTRUDA & expanding cancer pipeline
Highlighting KEYTRUDA & expanding cancer pipeline
Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
The accrued data from the Phase 3 study suggest that the baseline characteristics of the enrolled patients are consistent with those observed in previous studies
We are building an AI-native operating system for pharma sales and distribution
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
The medical-grade Angelas diode laser calibrated at a 1470 nm wavelength supports microsurgeries across multiple specialties
Subscribe To Our Newsletter & Stay Updated